BioCentury | Apr 23, 2019
Finance

Accelerating innovations in Cambridge

...stage opportunities.” Start Codon’s board will comprise Mellad, who was CEO of blood-based diagnostics company Cambridge Epigenetix Ltd....
BioCentury | Sep 7, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...Lynparza olaparib. Balasubramanian was a scientific founder of microarray company Solexa Inc. and sequencing play Cambridge Epigenetix Ltd....
BioCentury | Sep 4, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...Lynparza olaparib. Balasubramanian was a scientific founder of microarray company Solexa Inc. and sequencing play Cambridge Epigenetix Ltd....
BioCentury | Jul 27, 2018
Product R&D

Syncona’s sister act

...Ltd. and diagnostics company Blue Earth Diagnostics Ltd. The firm has also made investments in Cambridge Epigenetix Ltd....
...Amsterdam, the Netherlands Autolus Therapeutics plc (NASDAQ:AUTL), London, U.K. Blue Earth Diagnostics Ltd., London, U.K. Cambridge Epigenetix Ltd....
BioCentury | Nov 3, 2017
Company News

Management tracks: Tissue Regenix, Therapix

...chairman, Ascher Shmulewitz, interim CEO. Elran Haber stepped down as CEO in May. Epigenetics company Cambridge Epigenetix Ltd....
BioCentury | Nov 8, 2016
Financial News

Syncona pooling resources with U.K. cancer investors

...network. BACIT shareholders will vote on the proposal in December. Syncona-backed biotechs include sequencing play Cambridge Epigenetix Ltd....
BioCentury | Mar 21, 2016
Financial News

Cambridge Epigenetix completes venture financing

Cambridge Epigenetix Ltd. , Babraham, U.K. Business: Genomics, Supply/Service Date completed: 2016-03-14 Type: Venture financing Raised: $21 million Investors: GV; Sequoia Capital; New Science Ventures; Syncona Partners LLP; Cambridge University WIR Staff...
BioCentury | Mar 15, 2016
Financial News

Cambridge Epigenetix raises $21M in series B round

...base pairs at single-base resolution based on the company's TrueMethyl oxidative bisulfite sequencing (oxBS-Seq) technology. Cambridge Epigenetix...
...lead and VP of product development at Illumina Inc. (NASDAQ:ILMN). GV's Tom Hulme will join Cambridge Epigenetix's...
BioCentury | Feb 26, 2015
Finance

Europe waking to the American dream

...Molecular Biology U.K. Atlas Venture; Novartis Venture Funds; SR One; SV Life Sciences; Astellas Venture Cambridge Epigenetix Ltd.(Epigenetic...
BioCentury | Nov 3, 2014
Financial News

Cambridge Epigenetix completes venture financing

Cambridge Epigenetix Ltd. , Babraham, U.K. Business: Genomics, Supply/Service Date completed: 2014-10-29 Type: Venture financing Raised: $5.5 million Investors: New Science Ventures; Syncona Partners LLP; Cambridge Enterprise WIR Staff...
Items per page:
1 - 10 of 12
BioCentury | Apr 23, 2019
Finance

Accelerating innovations in Cambridge

...stage opportunities.” Start Codon’s board will comprise Mellad, who was CEO of blood-based diagnostics company Cambridge Epigenetix Ltd....
BioCentury | Sep 7, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...Lynparza olaparib. Balasubramanian was a scientific founder of microarray company Solexa Inc. and sequencing play Cambridge Epigenetix Ltd....
BioCentury | Sep 4, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...Lynparza olaparib. Balasubramanian was a scientific founder of microarray company Solexa Inc. and sequencing play Cambridge Epigenetix Ltd....
BioCentury | Jul 27, 2018
Product R&D

Syncona’s sister act

...Ltd. and diagnostics company Blue Earth Diagnostics Ltd. The firm has also made investments in Cambridge Epigenetix Ltd....
...Amsterdam, the Netherlands Autolus Therapeutics plc (NASDAQ:AUTL), London, U.K. Blue Earth Diagnostics Ltd., London, U.K. Cambridge Epigenetix Ltd....
BioCentury | Nov 3, 2017
Company News

Management tracks: Tissue Regenix, Therapix

...chairman, Ascher Shmulewitz, interim CEO. Elran Haber stepped down as CEO in May. Epigenetics company Cambridge Epigenetix Ltd....
BioCentury | Nov 8, 2016
Financial News

Syncona pooling resources with U.K. cancer investors

...network. BACIT shareholders will vote on the proposal in December. Syncona-backed biotechs include sequencing play Cambridge Epigenetix Ltd....
BioCentury | Mar 21, 2016
Financial News

Cambridge Epigenetix completes venture financing

Cambridge Epigenetix Ltd. , Babraham, U.K. Business: Genomics, Supply/Service Date completed: 2016-03-14 Type: Venture financing Raised: $21 million Investors: GV; Sequoia Capital; New Science Ventures; Syncona Partners LLP; Cambridge University WIR Staff...
BioCentury | Mar 15, 2016
Financial News

Cambridge Epigenetix raises $21M in series B round

...base pairs at single-base resolution based on the company's TrueMethyl oxidative bisulfite sequencing (oxBS-Seq) technology. Cambridge Epigenetix...
...lead and VP of product development at Illumina Inc. (NASDAQ:ILMN). GV's Tom Hulme will join Cambridge Epigenetix's...
BioCentury | Feb 26, 2015
Finance

Europe waking to the American dream

...Molecular Biology U.K. Atlas Venture; Novartis Venture Funds; SR One; SV Life Sciences; Astellas Venture Cambridge Epigenetix Ltd.(Epigenetic...
BioCentury | Nov 3, 2014
Financial News

Cambridge Epigenetix completes venture financing

Cambridge Epigenetix Ltd. , Babraham, U.K. Business: Genomics, Supply/Service Date completed: 2014-10-29 Type: Venture financing Raised: $5.5 million Investors: New Science Ventures; Syncona Partners LLP; Cambridge Enterprise WIR Staff...
Items per page:
1 - 10 of 12